ÇÒÀιæ
Clinics- Àú³Î ´ÜÇົ
µðÁöÅÐ, ÀΰøÁö´ÉÀÇÇÐ
µ¿¹°º¸°Ç»ç
Çѱ۵µ¼­ ±âÃÊ
Çѱ۵µ¼­ ³»°ú
Çѱ۵µ¼­ ¿Ü°ú
Çѱ۵µ¼­ ¿µ»ó/¾È°ú/Ä¡°ú
Çѱ۵µ¼­ ±âŸ
±âÃÊ »ý¸íÀÇ°úÇÐ
½ÇÇ赿¹°
¼öÀÇ À±¸®/º¹Áö
±â»ýÃæ/»ê°ú/À¯Àü
°øÁߺ¸°Ç/Àü¿°º´ÇÐ
µ¶¼º/¾à¸®,¾àÀü
¸é¿ª/¹Ì»ý¹°ÇÐ
¹ß»ý/ÇغÎ/»ý¸®ÇÐ
Á¶Á÷/º´¸®ÇÐ
¼ö»ýµ¿¹°
Á¶·ù
»ê¾÷/Áß,´ëµ¿¹°
µÅÁö
¸»
¼Ò
°í¾çÀÌ
µ¿¹° º¸Á¤,Çڵ鸵
¼öÀÇ ÀϹÝ/±âŸ Âü°íµµ¼­
¼Òµ¿¹° ³»°ú
¼Òµ¿¹° ¿Ü°ú
ÀçÈ°/½Å°æ, Á¤Çü¿Ü°úÇÐ
³»½Ã°æ, ÀÚ·É/³ë·Éµ¿¹°ÇÐ
ºñ´¢±â/À̺ñÀÎÈÄ°ú
¸¶Ãë,ÅëÁõ/ÀÀ±Þ,¼ö¾×
¼ÒÈ­/¿µ¾ç/ÇǺÎÇÐ
³»ºÐºñ/½Å°æ/ÇൿÇÐ
½ÉÀå,È£Èí±â/Á¾¾çÇÐ
¾È°ú/Ä¡°úÇÐ
¿µ»óÁø´ÜÀÇÇÐ
ÀÓ»óº´¸®(¼¼Æ÷,Ç÷¾×ÇÐ)
´ëüÀÇÇÐ(ħ¼ú,Çãºê)
¾ß»ý/Ư¼öµ¿¹° Exo, Zoo
Á¾º¸Á¸/µ¿¹°º¸È£/¹ýÀÇÇÐ
º´¿ø°æ¿µ/»çÀü/¿ë¾î
BSAVA ½Ã¸®Áî
ÀÚÀ¯°áÁ¦
100ÀÚ ¼­Æò
Áú¹®°ú ´ë´ä
  T: 042-330-0039

  042-361-2500

  HP: 010-8364-0400

  F: 042-367-1017

ÆòÀÏ 10:00 ~ 18:00


À̸ÞÀϹ®ÀÇ
½ÅÇÑ 100-023-144280
±¹¹Î 732801-01-097961
³óÇù 453131-56-197831
Çϳª 660-910336-13307
¿¹±ÝÁÖ: ÀÌ»óµ· okvet
 
 
ºñ¹Ð¹øÈ£ È®ÀÎ ´Ý±â
½ÇÇ赿¹° > Academic Press > Haschek and Rousseaux's Handbook of Toxicologic Pathology, 4e Volume 1: Principles and Practice of Toxicologic Pathology

 
Haschek and Rousseaux's Handbook of Toxicologic Pathology, 4e Volume 1: Principles and Practice of Toxicologic Pathology
»óÇ°¸í : Haschek and Rousseaux's Handbook of Toxicologic Pathology, 4e Volume 1: Principles and Practice of Toxicologic Pathology
Á¦Á¶È¸»ç : Academic Press
¿ø»êÁö : USA
Àû¸³±Ý¾× : 10,740¿ø
¼ÒºñÀÚ°¡ : 358,000¿ø
ÆǸŰ¡°Ý : 358,000¿ø
¼ö·® EA
 
¹è¼ÛÁ¶°Ç : (Á¶°Ç)
   
 

Haschek and Rousseaux's Handbook of Toxicologic Pathology, 4e Volume 1: Principles and Practice of Toxicologic Pathology



Editors: Wanda Haschek, Colin Rousseaux, Matthew Wallig, Brad Bolon
ISBN: 9780128210444
Imprint: Academic Press
Published: October 2021
Pages: 1152



Description


Haschek and Rousseaux's Handbook of Toxicologic Pathology, recognized by many as the most authoritative single source of information in the field of toxicologic pathology, has been extensively updated to continue its comprehensive and timely coverage. The fourth edition has been expanded to four separate volumes due to an explosion of information in this field requiring new and updated chapters. Completely revised with a number of new chapters, Volume 1, "Principles and the Practice of Toxicologic Pathology," covers the practice of toxicologic pathology in three parts: Principles of Toxicologic Pathology, Methods in Toxicologic Pathology, and the Practice of Toxicologic Pathology. Other volumes in this work round out the depth and breadth of coverage.Volume 2 encompasses "Toxicologic Pathology in Safety Assessment" and "Environmental Toxicologic Pathology". These two sections cover the application of toxicologic pathology in developing specific product classes, principles of data interpretation for safety assessment, and toxicologic pathology of major classes of environmental toxicants. Volumes 3 and 4 provide deep and broad treatment of "Target Organ Toxicity", emphasizing the comparative and correlative aspects of normal biology and toxicant-induced dysfunction, principal methods for toxicologic pathology evaluation, and major mechanisms of toxicity. These volumes comprise the most authoritative reference on toxicologic pathology for pathologists, toxicologists, research scientists, and regulators studying and making decisions on drugs, biologics, medical devices, and other chemicals, including agrochemicals and environmental contaminants. Each volume is being published separately.



Key Features


  • Provides new chapters on digital pathology, juvenile pathology, in vitro/in vivo correlation, big data technologies and in-depth discussion of timely topics in the area of toxicologic pathology
  • Offers high-quality and trusted content in a multi-contributed work written by leading international authorities in all areas of toxicologic pathology
  • Features hundreds of full-color images in both the print and electronic versions of the book to highlight difficult concepts with clear illustrations


  • Readership


    Scientists, including pathologists, toxicologists and graduate students, in academia, industry and government. Potential settings include biopharmaceutical, medical device, and chemical companies; contract and basic research organizations; veterinary diagnostic laboratories and medical forensic laboratories; regulatory agencies and universities



    Table of Contents


    Cover image
    Title page
    Table of Contents
    Copyright
    Dedication
    Contributors
    About the Editors
    Preface to the 4th Edition

    Chapter 1. Toxicologic Pathology: An Introduction
    1. An Overview of Toxicologic Pathology
    2. What Is Toxicologic Pathology?
    3. The Basis of Toxicologic Pathology
    4. Challenges in Toxicologic Pathology
    5. Training and Certification in Toxicologic Pathology
    6. The ¡°Practitioner¡± of Toxicologic Pathology
    7. Summary

    Part 1. Principles of Toxicologic Pathology

    Chapter 2. Biochemical and Molecular Basis of Toxicity
    1. Introduction
    2. General Principles of Xenobiotic Disposition
    3. Interactions of Toxicants with Cellular and Molecular Targets
    4. Idiosyncratic Mechanisms of Toxicity
    5. Protective Mechanisms, Repair Mechanisms, and Adaptation or Failure
    6. Summary and Conclusions

    Chapter 3. ADME Principles in Small Molecule Drug Discovery and Development: An Industrial Perspective
    1. Introduction
    2. General ADME Principles
    3. Discovery Overview
    4. Absorption, Bioavailability, and PK/TK Studies
    5. Distribution
    6. Metabolism
    7. Excretion
    8. Physiologically Based PK modeling
    9. Development
    10. Mass Balance Studies
    11. Tissue Distribution Studies
    12. Drug Metabolism Studies in Development
    13. Excretion Studies
    14. Specialized Excretion Studies
    15. General Timing of Development ADME Studies
    16. Conclusions

    Chapter 4. Biotherapeutics ADME and PK/PD Principles
    1. Introduction
    2. Pharmacokinetics of Biotherapeutics
    3. Pharmacodynamics of Biotherapeutics
    4. PK–PD Modeling and Interspecies Scaling
    5. Summary

    Chapter 5. Principles of Pharmacodynamics and Toxicodynamics
    1. Introduction: Definition of Pharmacodynamics and Toxicodynamics
    2. Mechanism of Drug Action and Adverse Drug Reaction
    3. Types of Adverse Drug Reaction: Intrinsic (Type A) Versus Idiosyncratic (Type B)
    4. Types of Xenobiotic–Target Interaction
    5. Exposure-Dependent Response
    6. Response Following Chronic Dosing
    7. Quantitative Modeling for Pharmacokinetic/Pharmacodynamic and Toxicodynamic Data Analysis

    Chapter 6. Morphologic Manifestations of Toxic Cell Injury
    1. Introduction
    2. Adaptation
    3. Irreversible versus Reversible Cell Injury
    4. Irreversible Cell Injury
    5. Conclusion

    Chapter 7. The Role of Pathology in Evaluation of Reproductive, Developmental, and Juvenile Toxicity
    1. Introduction
    2. Reproductive Toxicity Assessment
    3. Pregnancy and Developmental Toxicity
    4. Juvenile Toxicity Assessment
    5. Conclusions
    Abbreviations

    Chapter 8. Carcinogenesis: Mechanisms and Evaluation
    1. Introduction
    2. Mechanisms of Chemically Induced Carcinogenesis
    3. Identification of Carcinogens—Testing Programs and Guidelines
    4. Evolving and New Technologies
    5. Conclusions

    Part 2. Methods in Toxicologic Pathology

    Chapter 9. Basic Approaches in Anatomic Toxicologic Pathology
    1. Introduction
    2. General Considerations in Study Protocol Development
    3. In-Life Evaluations
    4. Necropsy
    5. Fixation and Histologic Procedures
    6. Specialized Histologic Techniques
    7. Histopathologic Evaluation
    8. Artifacts versus Lesions
    9. Diagnostic Challenges in Anatomic Toxicologic Pathology
    10. Conclusions

    Chapter 10. Clinical Pathology in Nonclinical Toxicity Testing
    1. Introduction
    2. Clinical Pathology Parameters Commonly Included in Protocols for General Toxicity Studies
    3. Nonstandard Biomarkers
    4. Conclusions

    Chapter 11. Special Techniques in Toxicologic Pathology
    1. Introduction
    2. Immunohistochemistry
    3. Enzyme Histochemistry
    4. In Situ Hybridization
    5. Flow Cytometry
    6. Laser Capture Microdissection
    7. Confocal Microscopy
    8. Electron Microscopy
    9. Stereology
    10. Digital Pathology
    11. Conclusions
    Glossary

    Chapter 12. Digital Pathology and Tissue Image Analysis
    1. Introduction
    2. Whole-Slide Imaging
    3. Tissue Image Analysis
    4. Regulatory Considerations for Digital Pathology Evaluation
    5. Related Topics
    6. Conclusion

    Chapter 13. In Vivo Small Animal Imaging: A Comparison to Gross and Histopathologic Observations in Animal Models
    1. Introduction
    2. Magnetic Resonance Imaging and Magnetic Resonance Microscopy
    3. Computed Tomography
    4. Radionuclide-based Imaging: PET and SPECT
    5. Optical Imaging
    6. Ultrasound
    7. Translational Application, Safety Assessment, and Drug Screening with In Vivo or Ex Vivo Imaging
    Abbreviations for Imaging Modalities

    Chapter 14. Biomarkers: Discovery, Qualification, and Application
    1. Introduction
    2. Categories of Biomarkers
    3. Strategies for Discovery of Biomarkers
    4. Methods for Biomarker Measurement and Quantitation
    5. Qualification of Biomarkers: Major Considerations

    Chapter 15. Toxicogenomics: A Primer for Toxicologic Pathologists
    1. Introduction
    2. Basics of Toxicogenomics
    3. Overview of Toxicogenomic Technologies
    4. Key Considerations for Conducting Toxicogenomic Studies
    5. Goals and Applications of Toxicogenomic Studies
    6. Sample Considerations
    7. Applications of Toxicogenomics
    8. Regulatory Considerations
    9. Conclusions
    Glossary

    Chapter 16. Experimental Design and Statistical Analysis for Toxicologic Pathologists
    1. Introduction
    2. Considerations Made Before Designing the Experiment
    3. Experimental Design
    4. Designs Commonly Used in Toxicologic Pathology
    5. Functions of Statistical Analyses
    6. Prerequisites to Statistical Analysis
    7. Statistical Methods
    8. Interpretation of Results
    9. Data Analysis Applications in Toxicologic Pathology
    10. Assumptions of Statistical Tests
    11. Summary and Conclusions
    Glossary

    Part 3. Animal and Alternative Models in Toxicologic Research

    Chapter 17. Animal Models in Toxicologic Research: Rodents
    1. Introduction
    2. Rodent Model Selection
    3. Issues in Extrapolation of Rodent Data for Human Risk Assessment
    4. Basic Biological Characteristics of Common Rodent Stocks and Strains
    5. Common Pathologic Findings in Rodents
    6. Conclusion

    Chapter 18. Animal Models in Toxicologic Research: Rabbit
    1. Introduction
    2. Model Selection
    3. Basic Biological Characteristics and Common Breeds
    4. Regulatory Aspects and Examples of Use of Rabbits in Biomedical Research
    5. Pharmacokinetic and Toxicity Studies
    6. Major Disease and Functional Models (Other than Safety)
    7. Spontaneous Findings in the Experimental NZW Rabbit

    Chapter 19. Animal Models in Toxicologic Research: Dog
    1. Introduction
    2. History and Derivation of Beagles
    3. Use of Dogs in Biomedical Research
    4. Predictivity of Dog Toxicity Data to Humans
    5. Comparative Toxicology of the Dog
    6. Spontaneous Background Pathology in the Beagle (Refer to Woicke et al., 2021)
    7. Use of the Dog as a Model of Human Diseases
    8. Regulatory Considerations for Toxicity Studies
    9. Ethics of Use of the Dog as a Laboratory Animal Species
    10. Summary

    Chapter 20. Animal Models in Toxicologic Research: Pig
    1. Introduction
    2. Genetics of Pigs and Background for Their Use in Research
    3. Use of Pigs in Toxicological Studies
    4. Pigs as Organ Source for Xenotransplantation
    5. Spontaneous Background Pathology in Swine
    6. Use of the Pig as a Model System for Medical Devices and of Human Diseases
    7. Regulatory Aspects
    8. Ethics and Animal Welfare
    9. Summary

    Chapter 21. Animal Models in Toxicologic Research: Nonhuman Primate
    1. Introduction
    2. History and Biological Characteristics of Nonhuman Primates
    3. Selection of Nonhuman Primates for Toxicologic Research and Study Design Considerations
    4. Predictivity of Nonhuman Primate Toxicity Data to Humans
    5. Nonhuman Primate Models in Biomedical Research (see also (Abee, Mansfield, Tardif, & Morris, 2012)
    6. Background Findings in Nonhuman Primates and Use of Historical Control Data
    7. Conclusion

    Chapter 22. Animal Models in Toxicologic Research: Nonmammalian
    1. Introduction
    2. Nonmammalian Animal Taxa
    3. Utilization of Nonmammalian Animals
    4. Study Design Considerations
    5. Data Extrapolation
    6. Conclusions

    Chapter 23. Genetically Engineered Animal Models in Toxicologic Research
    1. Fundamentals of Genetically Engineered Animal Models
    2. Analysis of Genetically Engineered Animal Models
    3. Genetically Modified Models for Hazard Identification and Safety Assessment
    4. Limitations in Using Genetically Modified Animals for Hazard Identification and Safety Assessment
    5. Special Considerations in Safety Assessment of Products Derived from Genetically Engineered Animals
    6. Summary
    Glossary

    Chapter 24. Alternative Models in Biomedical Research: In Silico, In Vitro, Ex Vivo, and Nontraditional In Vivo Approaches
    1. Introduction
    2. Nontraditional Models in Toxicity Research
    3. In Vitro and Ex Vivo Models
    4. In Silico Models and Data Analytics
    5. In Vivo Models Using Alternative Mammalian and Nonmammalian Species
    6. Regulatory Perspective on Alternative Models
    7. Conclusions and Perspectives

    Part 4. Practice of Toxicologic Pathology

    Chapter 25. Nomenclature and Diagnostic Resources in Anatomic Toxicologic Pathology
    1. Introduction
    2. The Need for Standardized Nomenclature
    3. Components in Nomenclature
    4. Challenges in Standardizing Nomenclature
    5. Recommended Practices
    6. Harmonization of Nomenclature
    7. Conclusions

    Chapter 26. Pathology Peer Review
    1. Introduction
    2. Peer Review Timing and Pathology Raw Data
    3. Peer Review Process
    4. National Toxicology Program Review Process
    5. Regulatory Aspects of Pathology Peer Review
    6. Use of Digital/Whole-Slide Images in Pathology Peer Review
    7. Conclusion

    Chapter 27. Pathology and GLPs, Quality Control, and Quality Assurance
    1. Introduction
    2. Overview of Good Laboratory Practice Standards
    3. GLP and Pathology Data
    4. Clinical Pathology Assessment in the GLP Environment
    5. Ultrastructural Assessment in the GLP Environment
    6. Noninvasive Imaging Applications in the GLP Environment
    7. In the Spirit of GLP
    8. GLP Criticism
    9. Conclusions

    Chapter 28. Practices to Optimize Generation, Interpretation, and Reporting of Pathology Data from Toxicity Studies
    1. Introduction
    2. Practices that Prevent or Mitigate the Introduction of Pathology-Related Issues During Study Design and Protocol Preparation
    3. Practices that Prevent or Mitigate the Introduction of Pathology-Related Issues Arising During the In-Life Phase
    4. Practices that Prevent or Mitigate Issues Arising from Pathology Assessment and Reporting
    5. Conclusions
    Glossary

    Chapter 29. Issues in Laboratory Animal Science That Impact Toxicologic Pathology
    1. Introduction
    2. Trends in Global Research Animal Care and Use
    3. Regulatory Issues
    4. Euthanasia of Research Animals
    5. Selection of Animal Models
    6. Animal Health Considerations
    7. Microbiome and Microbial Effects on Pathophysiology and Study Outcomes
    8. Housing and Husbandry Issues
    9. The Role of Diet in Toxicity Studies
    10. 3R's and In-Life Study Conduct for the Toxicologic Pathologist
    11. Description of Animal Studies in Scientific Publications
    12. Conclusion

    Index



    About the Editors


    Wanda Haschek

    Wanda M Haschek-Hock, BVSc, PhD, DACVP, FIATP, ‎Professor Emerita, Dept of Veterinary Pathobiology, College of Veterinary Medicine University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Professor Haschek-Hock has served as president of the Society of Toxicologic Pathology and the Society of Toxicology¡¯s Comparative and Veterinary Specialty Section, as well as Councilor of the American College of Veterinary Pathologists, board member of the American Board of Toxicology; as Associate Editor for Toxicological Sciences and for Toxicologic Pathology; as Editorial Board member for Fundamental and Applied Toxicology, Veterinary Pathology and Toxicologic Pathology. She has served as a member on the USFDA Veterinary Medicine Advisory Committee for the Center for Veterinary Medicine, the EPA¡¯s FIFRA Science Advisory Panel, and National Academy of Sciences Committee. She currently serves on the Board of Directors of the C.L. Davis Foundation for the Advancement of Veterinary and Comparative Pathology. She was awarded the Society of Toxicologic Pathology¡¯s Achievement Award in 2007 and the Midwest Regional Chapter – Society of Toxicology¡¯s Kenneth DuBois Award in 2011.


    Colin Rousseaux

    Professor Rousseaux, BVSc [Hons], PhD, DABT, FRCPath, FIATP, FATS is a Fellow of the Royal College of Pathology, Diplomate of the American Board of Toxicology, Fellow of the Academy of Toxicological Sciences, and Fellow of the International Academy of Toxicologic Pathology. He is Professor (Adjunct) in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada. He has 35 years of experience in comparative and toxicologic pathology with a research focus on herbal remedies, fetal development and teratology, and environmental pollutants. He has described, investigated, and evaluated numerous toxicologic pathology issues associated with pharmaceutical, pesticides, and agrochemicals. He has served on the editorial board of Toxicologic Pathology. He is a former president of the Society of Toxicologic Pathology.


    Matthew Wallig

    Professor Wallig, DVM, PhD, DACVP is a Diplomate of the American College of Veterinary Pathologists. He is Professor Emeritus in the Department of Pathobiology, College of Veterinary Medicine, the Department of Food Science and Human Nutrition, as well as the Division of Nutritional Sciences at the University of Illinois. His research has focused on the chemoprotective properties and mechanisms of phytochemicals in the diet, in particular those in cruciferous vegetables and soy, and the pathophysiology of pancreatic injury.


    Brad Bolon

    Brad Bolon, DVM, MS, PhD, DACVP, DABT, FATS, FIATP, President and Pathologist, GEMpath, Inc., Longmont, Colorado, USA During a 25-year career, Dr. Bolon has been employed in academia, contract research organizations, and two pharmaceutical firms before launching an experimental and toxicologic pathology practice. His main professional interests include comparative pathology of genetically engineered animals and toxicologic neuropathology. He is a past president of the Society of Toxicologic Pathology and is a recipient of the 2018 British Society of Toxicological Pathology¡¯s Gopinath Lecture Award for excellence in toxicologic pathology.



     
     
     
     
    »óÈ£¸í : OKVET »ç¾÷ÀÚµî·Ï¹øÈ£ : 314-90-93001 314-90-93001 Åë½ÅÆǸž÷½Å°í¹øÈ£ : À¯¼º±¸Ã» Á¦2006-75È£
    [ÀÌ¿ë¾à°ü] [°³ÀÎÁ¤º¸ 󸮹æħ] °³ÀÎÁ¤º¸ º¸È£ Ã¥ÀÓÀÚ : ÀÌ»óµ· ´ëÇ¥ : ÀÌ»óµ·
    »ç¾÷Àå¼ÒÀçÁö : ´ëÀü±¤¿ª½Ã À¯¼º±¸ Å×Å©³ë3·Î 65, ÇѽŠS-MECA 440È£
    Copyright ¨Ï okvet All Rights Reserved. T: 042-330-0039, 042-361-2500, HP: 010-8364-0400, F: 042-367-1017